BioAro

About BioAro

BioAro utilizes genetic sequencing and analysis to develop personalized medicine solutions tailored to individual patient profiles. This approach provides targeted therapies that enhance treatment efficacy and minimize adverse effects, addressing the limitations of standard treatment protocols.

BioAro utilizes genetic sequencing and analysis to develop personalized medicine solutions tailored to individual patient profiles. This approach provides targeted therapies that enhance treatment efficacy and minimize adverse effects, addressing the limitations of standard treatment protocols.

What does BioAro do?

BioAro utilizes genetic sequencing and analysis to develop personalized medicine solutions tailored to individual patient profiles. This approach provides targeted therapies that enhance treatment efficacy and minimize adverse effects, addressing the limitations of standard treatment protocols.

Where is BioAro located?

BioAro is based in Calgary, Canada.

When was BioAro founded?

BioAro was founded in 2021.

Who founded BioAro?

BioAro was founded by Raman Kapoor and Anmol Kapoor.

  • Raman Kapoor - Chief Healthspan Officer and BioGut / Registered Dietitian / Founder NEA Precision Skin
  • Anmol Kapoor - CEO and Founder
Location
Calgary, Canada
Founded
2021
Employees
42 employees
B

BioAro

BioAro utilizes genetic sequencing and analysis to develop personalized medicine solutions tailored to individual patient profiles. This approach provides targeted therapies that enhance treatment efficacy and minimize adverse effects, addressing the limitations of standard treatment protocols.

Calgary, CanadaFounded 2021422K+ followers7/10 TractionRelative Traction Score based on online presence metrics compared to companies in the same age group.
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Features

  • BioAro utilizes genetic sequencing and analysis to develop personalized medicine solutions tailored to individual patient profiles. This approach provides targeted therapies that enhance treatment efficacy and minimize adverse effects, addressing the limitations of standard treatment protocols.
This profile is AI-generated and may contain inaccuracies.